Exact Sciences (STU:EXK) Pre-Tax Income : €-219 Mil (TTM As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Exact Sciences Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Exact Sciences's pretax income for the three months ended in Mar. 2024 was €-100 Mil. Its pretax income for the trailing twelve months (TTM) ended in Mar. 2024 was €-219 Mil. Exact Sciences's pretax margin was -17.01%.

During the past 13 years, Exact Sciences's highest Pretax Margin was -8.07%. The lowest was -5561.07%. And the median was -47.03%.

Exact Sciences Pre-Tax Income Historical Data

The historical data trend for Exact Sciences's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Exact Sciences Pre-Tax Income Chart

Exact Sciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Pre-Tax Income

Get a 7-Day Free Trial

-365.80

-681.49

-745.62

-597.15

-185.00

Exact Sciences Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Pre-Tax Income	Get a 7-Day Free Trial															-67.71	-73.77	0.98	-46.20	-99.75

Competitive Comparison of Exact Sciences's Pre-Tax Income

For the Diagnostics & Research subindustry, Exact Sciences's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Exact Sciences's Pre-Tax Income Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Exact Sciences's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Exact Sciences's Pre-Tax Income falls into.

Exact Sciences Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Exact Sciences's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-196.558	+	38.895	+	-22.394	+	0	+	-4.944
	=	-185

Exact Sciences's Pretax Income for the quarter that ended in Mar. 2024 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-94.082	+	1.626	+	-7.308	+	0	+	0.015999999999977
	=	-100

Pre-Tax Income for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-219 Mil.

Exact Sciences (STU:EXK) Pre-Tax Income Explanation

Exact Sciences's Pretax Margin for the quarter that ended in Mar. 2024 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	-99.748	/	586.522
	=	-17.01%

During the past 13 years, Exact Sciences's highest Pretax Margin was -8.07%. The lowest was -5561.07%. And the median was -47.03%.

Exact Sciences Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Exact Sciences's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Exact Sciences (STU:EXK) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Exact Sciences Corp (STU:EXK) » Definitions » Pre-Tax Income

Comparable Companies

QGEN CRL MEDP NTRA RVTY RDNT SHC GH NEOG DGX TMO DHR A IDXX IQV XSWX:LONN MTD ICLR WAT ILMN

Traded in Other Exchanges

EXAS:USA

Address

5505 Endeavor Lane, Madison, WI, USA, 53719

Website

https://www.exactsciences.com

Exact Sciences Corporation, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test, a noninvasive stool-based DNA test, is a pre-cancer screening test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening, too.